Trials / Active Not Recruiting
Active Not RecruitingNCT05931913
TMS + Exposure Therapy for Pediatric OCD
Transcranial Magnetic Stimulation to Augment Exposure and Response Prevention for Pediatric OCD
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Bradley Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will: * Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)
Detailed description
Pediatric OCD is a public health problem and many remain symptomatic even after receiving efficacious treatments. The success of exposure and response prevention (ERP), a first-line behavioral treatment, depends on the ability to refrain from compulsions during exposure tasks. Improving this "therapy critical behavior" is a potentially important strategy for ERP augmentation. Repetitive transcranial magnetic stimulation (rTMS) can be leveraged to stimulate healthier functioning of brain circuits underlying therapy critical behaviors. The overall objective of this project is to test whether augmenting ERP with rTMS over cortical nodes of select cortico-striatal circuits implicated in compulsivity can normalize connectivity and enhance response prevention in youth and young adults with OCD. This project will use a masked RCT design to test whether ERP+TMS engages 1) hypothesized circuits involved in compulsivity and 2) observed response prevention during ERP exposure tasks. Youth ages 12-21 years with OCD will complete a full course of ERP plus randomly assigned TMS regimens of sham, inhibitory theta burst stimulation (iTBS) to the dorsolateral prefrontal cortext (dlPFC), or continuous theta burst stimulation (cTBS) to the presupplementary motor area (pSMA; n=20 per group). Milestones for the R61 phase are determination that at least one active rTMS condition a) changes resting state functional connectivity in the hypothesized circuit within- and between-subjects and b) is safe and feasible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex | TMS will be delivered over the dorsolateral prefrontal cortex (dlPFC) using an intermittent bursting pattern |
| BEHAVIORAL | Exposure with Response Prevention | ERP will be delivered daily, immediately following TMS |
| DEVICE | Transcranial Magnetic Stimulation: Sham | Sham stimulation will use the Magstim sham air-cooled coil, which produces auditory signals and appears identical to an active coil but contains a mu-metal shield that diverts the majority of the magnetic flux such that a minimal (\<3%) magnetic field is delivered to the cortex |
| DEVICE | Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area | TMS will be delivered over the pre supplementary motor area (preSMA) using a continuous bursting pattern |
Timeline
- Start date
- 2024-03-20
- Primary completion
- 2026-06-30
- Completion
- 2026-07-31
- First posted
- 2023-07-05
- Last updated
- 2026-04-08
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05931913. Inclusion in this directory is not an endorsement.